Biomanufacturing for Advanced Therapies Training Program
The biomanufacturing sector for advanced therapies is experiencing rapid growth and an escalating demand for personnel with specialized skill sets compared to conventional biopharmaceutical manufacturing. To address this need, OBIO® and CATTI have partnered to deliver the Biomanufacturing for Advanced Therapies Training Program, including cell and gene therapy (CGT), funded by Upskill Canada [powered by Palette Skills] and the Government of Canada.
The program focuses on both conceptual and practical skills essential to the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs), with a curriculum developed through extensive collaborations with companies in the sector developing CGTs and tailored to meet their specialized workforce needs.
Upcoming sessions:
August 11 - 15 | Aseptic Techniques & Cell Culture – Ottawa
August 25 - 29 | Aseptic Techniques & Cell Culture – Guelph
Designing AI-Ready Labs: From Data Chaos to Intelligence
Are you a biotech start-up or academic lab looking to turn your traditional lab into an AI-powered lab?
Join us on for this hands-on workshop supported by OBIO® and featuring guest speaker Guru Singh, CEO of Scispot, to learn how to transform messy lab data into structured, AI-ready formats that drive discovery and turn chaos into a competitive advantage.
Guest Speaker:
Guru Singh
CEO of Scispot
Date: Tuesday, July 29, 2025
Time: 11:30 am–1:30 pm
Location:
Schwartz Reisman Innovation Campus
108 College Street, Toronto, ON, M5G 0C6
Learn how to:
Structure your lab data
Automate data pipelines
Build scientific knowledge graphs
Prepare for AI
Key takeaways:
AI-ready data roadmap
Greater efficiency
Deeper insights
Future-proofing skills
*Bonus*
Participants will get a copy of the AI-Ready Labs Playbook, packed with best practices, checklists and templates.
Space is limited, and this high-impact session will fill up fast!
Networking Mixer: Brewing up connections in Biomanufacturing
Networking Mixer:
Brewing up connections in Biomanufacturing
OBIO® and CATTI are pleased to invite you to the upcoming Networking Mixer event in Ottawa, part of the Biomanufacturing for Advanced Therapies Training Program.
Hosted in partnership with Capital BioVentures, this evening mixer brings together past and current program participants, industry professionals, academic leaders, and innovators to build meaningful connections, exchange ideas, and spark future collaborations.
We look forward to seeing you there!
Buzzed for Bio
Buzzed for Bio
You’re invited to attend a fun night of summer networking hosted by CDD and OBIO®!
Join us for a relaxing, after-hours gathering bringing together biotech experts and members of the life sciences community. Come catch up with your peers or make some new connections!
When: July 10, 2025 at 5:30 pm
Where: Grizzly Bar in Toronto (739 Queen Street West)
What: A buzzing evening with some drinks & bites.
We hope you can make it and look forward to celebrating with you!
Space is limited, so register now.
OBIO® WiHI Breakfast: What You Need to Know About Raising Money in 2025
OBIO® WiHI Breakfast: What You Need to Know About Raising Money in 2025
Following the resounding success of the May 30 session on this exciting topic, we've decided to hold another one on June 23 to continue our conversation and provide more insights.
Were you unable to attend the May 30 session? Not a problem! You are welcome to join us on June 23.
Join OBIO® for a fireside chat with legal and venture capital experts
Sarah Farr, Senior Associate at Genesys Capital and Jennifer Humphrey, Associate, Emerging and High Growth Companies at Osler, Hoskin & Harcourt LLP to understand the current climate for fundraising.
This session will include:
Trends uncovered by Osler’s fourth annual “Deal Points Report: Venture Capital Financings”
Osler’s Emerging and High Growth Companies Group is an analysis of 646 anonymized venture capital and growth equity preferred share financings completed from 2020 to 2024, representing more than USD 11.5 billion in total transaction value.
Key implications for founders in life sciences and health tech raising money
We look forward to seeing you there!
*This is an invitation-only event.
The AI Opportunity: Revolutionizing Clinical Trials, Transforming Healthcare
The AI Opportunity: Revolutionizing Clinical Trials, Transforming Healthcare
Special event at the 2025 BIO International Convention in Boston
Clinical Trials Ontario, Life Sciences Ontario, and OBIO® are bringing industry and research leaders together in Boston for an in-person event showcasing how artificial intelligence is transforming clinical trials and healthcare delivery.
Join the event on Monday, June 16, 2025, at the Westin Boston Seaport District for a morning of insights and networking as we explore how artificial intelligence is reshaping clinical trials and the broader healthcare landscape.
Key discussion areas include:
Impact of AI on clinical trials and data integration
Ontario and Canada’s advantages in conducting AI-driven research and innovation
Opportunities to enhance patient care and accelerate therapeutic development
Designed for leaders in the pharmaceutical and medical device industries, CROs, and business and healthcare innovators, this event highlights the strength of Canada’s research ecosystem and its role in advancing the future of global healthcare.
Meet the panelists:
Dr. Christine Allen, PhD
CEO of Intrepid Labs;
Co-Director of Acceleration Consortium at UofT
Anthony de Fazekas
Partner, IP at Mintz
Sebastien Latapie
Partner at Avant BIO
Dr. Fahad Razak, MD,
Provincial Clinical Lead at Ontario Health; Co-Lead at GEMINI;
Canada Research Chair in Data-Informed Healthcare Improvement at UofT
Lucas Siow
Co-founder & CEO of ProteinQure
The event is sponsored by:
Funding Foundations: Navigating Your Start-up's Capital Raise
Join us for an informative session on June 10 in Ottawa co-hosted by Capital BioVentures and OBIO® designed to help entrepreneurs navigate the complex world of early-stage financing, and learn about essential topics and strategies such as:
Term sheets: Decoding key terms, negotiation strategies, and common pitfalls.
SAFEs vs. convertible notes vs. priced rounds: Understanding pros, cons, and when to use each instrument.
Valuation considerations: Valuation caps, how valuation caps work in SAFE notes, and discount rates.
Negotiation tactics: Approaches for successful investor discussions and agreement terms.
Legal & financial implications: Equity dilution, important clauses, and ongoing obligations.
This session will focus on practical advice and provide you with the strategies and tools you need to successfully navigate the start-up funding process. We look forward to seeing you there!
*This is an invitation-only event – sponsored by Osler, Hoskin & Harcourt LLP*
Registration for this event is now closed.
OBIO® WiHI Breakfast: What You Need to Know About Raising Money in 2025
OBIO® WiHI Breakfast: What You Need to Know About Raising Money in 2025
Join OBIO® for a fireside chat with legal and venture capital experts Sarah Farr, Senior Associate at Genesys Capital and Jennifer Humphrey, Associate, Emerging and High Growth Companies at Osler, Hoskin & Harcourt LLP to understand the current climate for fundraising.
This session will include:
Trends uncovered by Osler’s fourth annual “Deal Points Report: Venture Capital Financings”
Osler’s Emerging and High Growth Companies Group is an analysis of 646 anonymized venture capital and growth equity preferred share financings completed from 2020 to 2024, representing more than USD 11.5 billion in total transaction value.
Key implications for founders in life sciences and health tech raising money
We look forward to seeing you there!
*This is an invitation-only event.
Cybersecurity & Digital Health Training for Health Science Professionals
As Canada accelerates the commercialization and adoption of digital technologies into the fast-growing health science industry, there is a critical need to create high-value technology jobs and support the development of talent in the technology workforce.
OBIO® is proud to partner with Upskill Canada [powered by Palette Skills] and the Government of Canada to deliver the Cybersecurity & Digital Health Training for Health Science Professionals. Emphasis will be placed on the importance of cybersecurity in healthcare, examining the latest trends, potential threats, and their impact on the industry.
The program will provide focused upskilling to help fast-growing companies access the talent they need to thrive and prosper, while creating new career paths for workers to quickly transition into high-demand roles.
THE PROGRAM RUNS FROM
MAY 12 to AUGUST 22, 2025 (14 WEEKS):
Part I – Core Training Course (Weeks 1 & 2)
Dates: May 12 - 23, 2025
Time: 8:30 am – 1 pm ET daily
Format: Virtual
Part II – Career Advancement support (Weeks 3 to 14).
Format: Hybrid
During this time, program participants will have access to a range of benefits:
Workshops for Professional Skills Development including career advancement support, resume, interview preparation and 1:1 coaching sessions (virtual) as well as networking events (in person)
Applications will be accepted on a rolling basis.
Deloitte x OBIO Breakfast - Impact on Canadian Founders: Equity Considerations for US and Cross-Border Corporate Tax
Join us for a morning of insightful conversation and networking at the Deloitte x OBIO Breakfast on May 6, focused on the impact of venture financing from the US and the impact of cross-border corporate tax for Canadian life-science founders. This event is a great opportunity to hear from tax liability experts, ask your questions, and connect with peers navigating similar challenges as they take on sizable foreign investment.
We'll be discussing consideration for expansion into the US with the impact on corporate taxes, ensuring your company is optimally structured for getting high exit milestones without incurring significant tax burdens, as well as price transfers and exchangeable shares when onboarding foreign shareholders.
You'll surely leave with practical knowledge to help guide your next steps. Coffee and breakfast will be served—come hungry for both food and ideas!
Meet the Experts:
Jigna Shah - Partner, Global Investment and Innovation Incentives
Brent Osborne - Partner, International Tax
Michael Xiang - Partner, US Tax
Teresa Russomanno - Director, Business Tax
Chris Watt Bickley - Partner, Cross Border Tax
Lynn Wu - Senior Manager, Business Tax
*Note: Approval Required. Your registration is subject to approval by the host*
OBIO® WiHI Breakfast: Benefits of Being a Canadian-controlled Private Corporation
OBIO® WiHI Breakfast: Benefits of Being a Canadian-controlled Private Corporation
Join us at our next breakfast session featuring guest speakers Gary Marshall (Partner, Emerging and High Growth Companies at Osler, Hoskin & Harcourt LLP) and Jennifer Humphrey (Associate, Emerging and High Growth Companies at Osler, Hoskin & Harcourt LLP).
This session will cover the following topics:
Benefits of Being a CCPC: We will explore the advantages Canadian-Controlled Private Corporations (CCPCs) offer, including access to government credits and grants, tax deferrals and strategic planning on an exit and benefits to Canadian option holders.
Considerations for Delaware Continuance: We will briefly discuss the various considerations and implications for entities contemplating a move to Delaware to help founders make an informed decision.
We look forward to seeing you there!
*This is an invitation-only event.
OBIO® WiHI Breakfast: Setting up a Life Sciences Business in the UK - Tips & Strategies
OBIO® WiHI Breakfast: Setting up a Life Sciences Business in the UK - Tips & Strategies
Join us at our next OBIO® Women in Health Initiative (WiHI) breakfast on March 27 for an insightful session designed to help life sciences start-ups establish themselves in the UK.
We will be welcoming guest speakers Emily Addison (Country Director, Canada at UK Department of Business and Trade), and Rachael Stevens (Head of Science and Innovation – Ontario at Foreign, Commonwealth and Development Office).
This session will address the following topics:
Overview of the UK life sciences sector; R&D strengths, clusters
Why would companies want to set up in the UK
How to set up in the UK and work with the UK Department of Business and Trade
Government incentives
Key high-growth areas - Health AI/ Digital Health, Medical Technical technology (prevention and early diagnosis); Cell & Gene therapy, Sustainability in the NHS, Engineering Biology
We look forward to seeing you there!
*This is an invitation-only event.
OBIO’s International Women's Day Celebration
OBIO’s International Women's Day Celebration
OBIO’s International Women’s Day Celebration will bring together dynamic women leaders across the health tech and life sciences industry. This event is a unique platform where investors, entrepreneurs, and industry professionals will gather to celebrate and empower women-driven innovations.
Event Highlights:
We will be hosting a panel discussion on "Future-Proofing Your Company and Career: Navigating the Evolving Landscape of Life Sciences".
WiHI Seed companies will pitch their groundbreaking solutions, showcasing the incredible potential of women-led start-ups to advance the future of healthcare.
Agenda
-
Registration & networking
-
Welcome & Opening Remarks
Dr. Maura Campbell, President & CEO, OBIO®
Cate Murray, President & CEO, Stem Cell Network
-
Panel discussion:
“Future-Proofing Your Company and Career: Navigating the Evolving Landscape of Life Sciences".Panelists:
Connie Chen, PhD - Sr. Director, Strategy & Corporate Development at FACIT
Jennifer Humphrey - Associate, Emerging and High Growth Companies at Osler, Hoskin & Harcourt LLP
Catherine Hunter - Partner and National Leader, Consumer Health and Life Sciences at EY
Cheryl J. Kerr - Founder and President of Medex Health Services Incorporated
Moderator: Maura Campbell, PhD - President and CEO of OBIO®
-
Networking break
-
Join us to listen to 5-minute pitches from 7 WiHI Seed companies.
AiimSense
Aptec Health
Asima Health
Cura Therapeutics
Flutter Care
SanoLiving
Women’s Global Health Innovation (BFree Cup)
-
Announcements & Pitch Prizes Distribution
-
Closing remarks
-
Networking
Meet our panelists
-
With over 20 years of experience in life sciences, biotech and capital markets, Dr. Connie Chen brings extensive experience in investment banking, seed investing, start-up and corporate development to her role at FACIT. FACIT is an award-winning commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation. Its portfolio includes Triphase Accelerator, Turnstone Biologics, and Fusion Pharmaceuticals, and which has attracted over $1 billion in investment to Ontario. Dr. Chen is part of the senior leadership at FACIT, driving strategies to translate biotechnologies into business opportunities, grow sustainable start-ups and establish commercial partnerships to drive value for cancer assets. Dr. Chen’s broad investment, transaction and strategic experience arises from various corporate development, investor relations and equity research roles including at Functional Technologies (Renaissance BioScience), Loewen, Ondaatje and McCutcheon, and Clarus Securities. Dr. Chen holds a PhD in Pharmaceutical Sciences from the University of Toronto.
-
Jennifer is an associate in our Emerging and High Growth Companies Group. Her practice focuses on advising a wide range of clients on matters including mergers and acquisitions, continuous disclosure, equity and debt financings, as well as general corporate and securities related matters.
Prior to joining Osler, Jennifer worked as a corporate securities associate at a leading regional Bay Street firm. She is an active member of the legal community and is a mentor to first year law students at Ryerson University.
-
Catherine is a Partner and the National Life Sciences Leader with EY Canada. Throughout her 25+ year career in consulting and industry, Catherine has worked with health service providers, pharmaceutical and med tech companies, and government to develop and deliver health-focused strategies and technology-enabled transformations for strategic growth, operational improvement and consumer focus. Catherine brings a deep understanding of the health ecosystem and has a particular interest in innovation and how diverse organizations can effectively work together to meet Canadians’ evolving health needs.
Catherine holds an MBA (Health Services Management) from McMaster University and a BScH (Life Sciences) from Queen’s University. She has served on several health related Boards at local and national levels, and is currently a Board Director with the Women’s Brain Health Initiative.
-
Ms. Kerr is a serial health services entrepreneur with over 30 years’ experience as a leader in the healthcare field.
Ms. Kerr has honed vast diagnostic and paramedical experience through her tenure at Med Chem Laboratories, Rapidmed Paramedical and Gamma Dyna Care laboratory services. Having mastered the full spectrum of medical diagnostics and home care services. Ms Kerr then launched MedEx Health Services in 2008 with operations in Canada and the USA.
Ms. Kerr’s expertise includes outpatient care and ambulatory services, with an emphasis on coordinating and implementing rehabilitation services in the accident benefits and disability management industry. MedEx has developed into one of Ontario’s leading accredited Black female-owned and operated, full-service rehabilitation and home healthcare company, catering to a diverse client base.
An active philanthropist and community advocate, Ms. Kerr is dedicated to supporting organizations that provide service and care to those who are less fortunate. For her efforts she was awarded the Bob Marley Toronto Humanitarian award for 2023.
Ms. Kerr is the 2020 recipient of the BBPA’s Harry Jerome female entrepreneur business Award as well as a 2020 100 Accomplished Black Canadian Women (100 ABC) Honoree. She was recognized by the RBC Champions for Women in 2006, and also received The National African American Insurance Association Award in 2007. She has established a distinguished reputation with various professional organizations, such as the Ontario Brain Injury Association, the Canadian Spinal Cord Injury Rehabilitation Association, and The Black Physicians Association of Ontario.
-
Dr. Maura Campbell is the President and CEO of OBIO®, a not-for-profit, membership-based organization dedicated to advancing health technology innovation and commercialization. Dr. Campbell has more than 30 years of experience in all key areas of biotech, including private and public companies, universities and research institutes, and government-funded public sector research organizations.
With expertise in technology transfer and commercialization of intellectual property, Dr. Campbell has held various roles in senior management, most recently as the Vice-President of Intellectual Property and Contracts for Turnstone Biologics, which recently went public on the NASDAQ. Previously, Dr. Campbell served as: Director, Intellectual Property at VBI Vaccines; Research Program Manager, and Manager of Technology Transfer & Commercialization at the Ottawa Hospital Research Institute; Director of Intellectual Property for PainCeptor Pharma Corporation; and Manager of Technology Transfer at the Institute for Robotics and Intelligent Systems National Centre of Excellence. Dr. Campbell has also served as an IP consultant to a number of Canadian start-ups including Neurochem, Conjuchem, Aonix, AMRIC and Sussex Research Labs.
Dr. Campbell received a Ph.D. in biochemistry from the University of Ottawa, and an M.Sc. and a B.Sc. in biochemistry from Queen’s University in Kingston. Dr. Campbell served as the Vice-Chair of Ontario’s Life Sciences Council, supporting a plan to make Ontario a top hub for innovation growth and life sciences investment. She currently serves as a board member for FACIT (a business accelerator and investor established by the Ontario Institute for Cancer Research), SPEC Labs (a life sciences incubator and healthcare & life sciences innovation hub) and Intellectual Property Ontario (a provincial agency providing trusted IP support for Ontario innovators).
Meet our pitching companies
The event is a great opportunity for attendees to network, collaborate, and invest in the next wave of healthcare innovations, while amplifying the voices of the women shaping the industry.
Thank you to our sponsors for their support!
OBIO® WiHI Breakfast: IP Strategy for Growth: From Concept to Commercialization - Developing an IP Roadmap
OBIO® WiHI Breakfast: IP Strategy for Growth: From Concept to Commercialization - Developing an IP Roadmap
Join us for our next event in the OBIO® WiHI Breakfast Series, "IP Strategy for Growth: From Concept to Commercialization - Developing an IP Roadmap."
This insightful session will feature Jean-Nicolas Delage, Partner, Emerging and High Growth Companies at Osler, which specializes in intellectual property strategy and transactions.
Jean-Nicolas will guide participants through the crucial steps of building and protecting an IP portfolio to support long-term growth, from initial concept to market entry. Drawing on his extensive experience in advising emerging technology companies and his expertise in patent pools and standardization processes, he will offer valuable insights on developing effective IP strategies.
We look forward to seeing you there!
*This is an invitation-only event.
Networking Reception at the OBIO® Investment Summit
As part of the 2025 OBIO® Investment Summit, OBIO® members and ecosystem partners are invited to join us for an evening of networking.
Date: Thursday, February 6
Time: 6 - 9 pm
Location:
Arcadian Court & Loft
401 Bay Street, Simpson Tower, 8th Floor
Toronto, ON M5H 2Y4
If you are already attending the Summit as a presenting company, Early Technology Showcase partner, sponsor or investor, then the reception is already included in your registration.
If you are a paid OBIO® member, check your inbox for a discount link or write to us at events@obio.ca.
Thank you to our Platinum sponsor Collaborative Drug Discovery for supporting the networking reception!
2025 OBIO® Investment Summit
2025 OBIO® Investment Summit
CANADA’S PREMIER HEALTH SCIENCE INVESTMENT EVENT
To learn more about the OBIO® Investment Summit, visit www.obioinvestmentsummit.com.
OBIO® WiHI Breakfast: Funding Foundations: Navigating Your Start-up's First Capital Raise
OBIO® WiHI Breakfast: Funding Foundations: Navigating Your Start-up's First Capital Raise
Kick off the new year with the first WiHI Women Leaders in Health breakfast of 2025!
Join us for an informative session designed to help entrepreneurs navigate the complex world of early-stage financing, and learn about essential topics and strategies such as:
Term sheets: Decoding key terms, negotiation strategies, and common pitfalls.
SAFEs vs. convertible notes vs. priced rounds: Understanding pros, cons, and when to use each instrument.
Valuation considerations: Valuation caps, how valuation caps work in SAFE notes, and discount rates.
Negotiation tactics: Approaches for successful investor discussions and agreement terms.
Legal & financial implications: Equity dilution, important clauses, and ongoing obligations.
This session will focus on practical advice and provide you with the strategies and tools you need to successfully navigate the start-up funding process.
We look forward to seeing you there!
*This is an invitation-only event.
Levelling the playing field: how Canadian health tech innovators can compete with U.S. companies during a time of protectionism
Levelling the playing field: how Canadian health tech innovators can compete with U.S. companies during a time of protectionism
Canadian health tech innovators are facing an increasingly complex landscape. With tight funding, a U.S. "home court" advantage, and a shifting political climate, succeeding in the global market – particularly the U.S. – is more challenging than ever.
Discover how to navigate these challenges as we explore C.H.I.E.F.S. (Canadian Health Innovation Evaluation For Success), a powerful tool created by Mammoth to help Canadian health SMEs compete with U.S. innovators.
Backed by empirical data, this tool is built on 50 proprietary criteria, grouped into 10 core functions and distilled into 6 key priorities.
Key Learning Objectives:
Recognize unappreciated deficiencies (use of funds and exit strategy)
Unlock the key to winning pitch competitions
Address the post-election uncertainty in the U.S. and how it affects your market approach
Given the recent U.S. election and the complete change in leadership, C.H.I.E.F.S. is more critical than ever to help navigate the evolving health tech landscape for innovators.
Reserve your spot today!
OBIO’s Annual General Meeting, Public Meeting & Reception 2024
OBIO’s Annual Public Meeting & Reception 2024
Get ready to celebrate with OBIO®!
Join us for our Annual Public Meeting and Reception for an evening of innovation, inspiration and fun on Thursday, December 5, from 5 to 8pm at the Royal Canadian Military Institute.
We’ll be celebrating our accomplishments in 2024 and taking the opportunity to thank our board of directors, members and ecosystem partners, embracing the spirit of collaboration.
This year’s event will be especially memorable, as we proudly celebrate OBIO's 15th anniversary.
✨ Special Highlights ✨
Improv Pitching Competition: Watch founders we've supported along their journey go off-script as they present “surprise” slide decks, challenging them to be spontaneous and inventive! Your vote will decide who your favourite presenter is!
Networking Reception: Enjoy drinks and hors d’oeuvres, catch up with friends and partners from other start-ups, ventures and the wider ecosystem—all while celebrating the spirit of innovation that makes us strong.
Registration spots are limited so please purchase your tickets early!
We look forward to seeing you there!
OBIO® WiHI Breakfast: Navigating Employment and Employee Incentives for Life Science Start-ups
OBIO® WiHI Breakfast: Navigating Employment and Employee Incentives for Life Science Start-ups
The OBIO® Women in Health Initiative (WiHI) is excited to announce its upcoming breakfast session on November 27, focusing on essential employment law and employee incentive strategies for start-ups. This session is ideally suited for start-up founders, executives and leaders in life sciences seeking practical guidance on the following topics:
Employee stock options and taxation - covering option grants, tax treatment, and market terms
Employee benefits and hiring & termination management
Take advantage of this opportunity to connect with fellow women leaders and pioneers in the field over breakfast, followed by engaging insights and a lively panel discussion. We look forward to seeing you there!
*This is an invitation-only event. Are you (or any women in your network) interested in attending? Click here and we will connect with you (or them).
Meet our guest speakers
Healthy IP Strategies in Life Sciences & Health Tech
Healthy IP Strategies in Life Sciences & Health Tech
Join us for an informative event where top IP experts, visionary founders, and industry leaders come together to share valuable insights on protecting your intellectual property and staying ahead in the fast-paced landscape of the life sciences and health tech industries!
Attendees will:
Learn how to protect their IP as healthcare innovators
Gain an understanding of IP strategies for different types of innovations
Understand how to prepare for due diligence and licensing
Uncover various IP support programs
Network with peers and industry leaders
Women Pioneers in Life Sciences: Leadership, Innovation, and Impact in Canada
Women Pioneers in Life Sciences: Leadership, Innovation, and Impact in Canada
Join us for the OBIO® Women Leaders in Life Sciences Breakfast Series featuring an inspiring panel discussion, Women Pioneers in Life Sciences: Leadership, Innovation, and Impact in Canada. This exclusive networking breakfast will bring together influential women leaders to share their journeys, insights, and challenges in shaping the future of life sciences in Canada.
Our distinguished panelists include:
Dr. Annie-Kim Gilbert, President & CEO, MEDTEQ+
Suzanne Grant, Executive Director, Capital Angel Network
Wendy Hurlburt, President & CEO, Life Sciences BC
Tessa Mintz, Chief Marketing Officer, Thornhill Medical
Moderated by Dr. Maura Campbell, President & CEO of OBIO®, the discussion will explore how these trailblazing women are driving innovation, fostering leadership, and making a lasting impact in the Canadian life sciences ecosystem.
Don't miss this opportunity to connect with fellow women leaders and pioneers in the field over breakfast, followed by engaging insights and a lively panel discussion.
We look forward to seeing you there!
Navigating CDMO Partnerships: A Practical Guide for Early-Stage Companies
Are you a biotech and pharma start-up going through drug discovery and development?
Equip yourself with the tools and practical knowledge to effectively collaborate with a Contract Development and Manufacturing Organization (CDMO) partner. This webinar taking place on October 16, from 12-1pm EDT will feature guest speaker Geoff Evans, President of Eurofins CDMO Alphora.
Join us and learn about:
The importance and role of a CDMO
The Request for Proposal (RFP) process
Key factors in selecting the right CDMO partner for your program
And more...
Pathways to Capital Raising
In partnership with Blake, Cassels & Graydon LLP and OBIO®, the Ontario Securities Commission is hosting an information session on the Ontario capital markets and recent regulatory changes that support early-stage capital raising for Ontario businesses.
Learn about sources of capital for early-stage life sciences and health tech companies and how to identify new investors. This event will focus on recent regulatory changes that have broadened the pool of investors in Ontario. The event will include an overview of the current investing climate and the implications for your business.
Medical Device Seminar: a CSA Group and OBIO Event
Are you involved with the manufacturing, designing, or regulatory compliance of medical devices?
In partnership with CSA Group, OBIO® is excited to invite you to attend a half-day seminar on Electrical Safety Testing & Certification, Electromagnetic Compatibility (EMC) Testing & Certification, and Global Market Access. This event, led by industry experts, will take place in Toronto (178 Rexdale Blvd) on October 2, 8 am - 1:30 pm.
Topics covered will include:
Choosing a test plan, understanding the process to complete testing and obtaining certification
Standards and regulations, testing procedures, and design & troubleshooting
Certification requirements for key markets and solutions for emerging & established global markets
Global Market Access regulatory compliance, standards and testing, and documentation & submissions.
This is a valuable opportunity to learn and expand your current knowledge of medical device testing and certification, ask industry experts questions, and network with fellow professionals.
Meet our guest speakers
-
Expertise: Electrical SafetyWith 13 years of experience at CSA Group, Kevin has developed an extensive understanding of the industry and its applicable standards. His expertise includes 8 years dedicated to certification, where he verifies whether products meet relevant requirements and standards. Kevin also holds a Professional Engineer designation.
-
Expertise: Electromagnetic CompatibilityPaul has been with CSA Group for 13 years. He has spent the last 3 years as a Product Group Manager. In this role, Paul oversees the Electromagnetic Compatibility (EMC) team, facilitating the successful management and execution of product testing and certification projects.
-
Expertise: Global Market AccessJose Luis has over 17 years of progressive experience in standards development, GMA, and conformity assessment in the energy efficiency, electrical safety, and the climate change and environmental areas.
AbbVie Partnering Day in Toronto
AbbVie Partnering Day in Toronto
Toronto | September 26, 2024
AbbVie, in collaboration with OBIO®, will host a Partnering Day in Toronto, bringing together researchers, entrepreneurs and biotech companies from Canada on September 26, 2024.
Note: This is a private event. All attendees will need to be pre-approved by the AbbVie team.
Agenda:
Morning: One-on-one partnering meetings with pre-selected companies
See instructions for meeting requests below.
Afternoon: AbbVie Showcase
Overview of AbbVie’s strategies and external innovation priorities
AbbVie’s approach to partnering
Networking reception
Participants must register in advance and be approved to attend the AbbVie Showcase.
One-on-one Partnering Meeting
Companies must apply in advance and be approved for a one-on-one partnering meeting. Please send a meeting request to partneringday@abbvie.com.
Selection Criteria
One-on-one meeting proposals will be evaluated by a panel of AbbVie reviewers by the following criteria:
Projects in all stages from discovery to clinical stage in our Areas of Interest
Strategic fit and differentiation from existing solutions
Deadline to submit applications: September 6, 2024
Limited seats for one-on-one meetings available.
AbbVie Delegates:
Niels Emmerich, VP, Global Head S&E and Alliances
Arpita Maiti, Head of S&E Immunology
Jenny Wang, Director, S&E Oncology
Murali Gopalakrishnan, Senior Director, S&E Neuroscience
Doug Faunce, Executive Director, Head of S&E Eye Care
Chinmay Kanuga, Senior Director, S&E Medical Aesthetics
Jay Stamatis, VP, BD&A
Christian Schubert, VP, AbbVie Ventures
FAQs
-
Please do not submit any confidential information as any submitted information be treated as non-confidential. Of course, we (AbbVie) will use this information only internally for evaluation purposes and will not further distribute.
-
You will have the opportunity and are encouraged to share supporting nonconfidential materials such as slide decks, research papers as part of your application.
-
No, a patent is not required to apply. However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.
-
Depending on the type and stage of development of the opportunity (from discovery to clinical) we have flexible partnership models (e.g. research collaborations, licensing and direct investments)
HBA’s Pitch Competition for Women Innovators
OBIO® is excited to partner with the Healthcare Businesswomen’s Association (HBA) on the Pitch Competition for Women Innovators, taking place in Toronto on September 25! Promising start-ups in the healthcare or life sciences sector with at least 51% female ownership will be participating in the Pitch Competition (read the press release) and:
Compete for prize money and present their innovation to judges from venture capital, private equity, and global healthcare sectors.
Connect with key industry players, potential investors, and fellow innovators.
Gain invaluable exposure and recognition for their start-up on an international stage.
For more information, please visit: HBA Pitch Competition.
About HBA
The Healthcare Businesswomen's Association (HBA) is a global organization spanning 75+ countries and with nearly 50 years of experience empowering women. HBA’s 175+ corporate partners represent a global workforce of nearly 6 million people. We believe by joining forces in the relentless pursuit of gender equity, we are doing more than uniting our 17,000+ passionate healthcare and life sciences professionals—we are strengthening the business of the healthcare ecosystem.
The OBIO® Women in Health Initiative (WiHI) received the 2023 HBA Advancement. Commitment. Engagement. (ACE) Honourable Mention, which is recognizing organizations committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA.
Risk Management in Life Sciences - The Role of Specialized Insurance
OBIO® Webinar
Risk Management in Life Sciences:
The Role of Specialized Insurance
Are you planning your product launch or thinking about your next clinical trial? Are you considering entering your first service contract with a strategic partner, or collaborating with a research partner requiring insurance coverage?
Get a crash course on life sciences insurance coverage and as a founder, understand your needs as you progress along your commercialization journey. The session will feature guest speakers from Jones DesLauriers Insurance Management, who will highlight and discuss case studies covering: Clinical Trial Risks, Cybersecurity insurance and data breach, and IP and R&D insurance coverage.
OBIO® WiHI Breakfast: Raising capital from Angel investors
Once a month, the OBIO® WiHI Professional Network (WiHI) hosts a breakfast with successful and inspiring women, inviting them to share their experiences, challenges and successes as they build and grow their companies in Canada.
Upcoming Breakfast session:
September 19 | 9 – 10:30 am | Toronto
The OBIO® Women in Health Initiative (WiHI) is pleased to announce its upcoming breakfast session on September 19, featuring a panel discussion on the essentials of raising capital from angel investors.
Register for this session to:
Explore the basics of securing funding from angel investors
Learn from our panel how to pitch effectively
Gain practical insights to confidently approach potential funders
Meet our panelists
This is an invitation-only event. Are you (or any women in your network) interested in attending? Click here and we will connect with you (or them).
The Privacy and Cybersecurity Framework for Start-ups in Health Science
Are you a start-up looking to navigate privacy considerations in the rapidly evolving landscape of technology innovation?
OBIO®, in partnership with Privacy Horizons Inc., is hosting a webinar to demonstrate that privacy and technological innovation can coexist.
This session will be led by guest speaker, Patrick Lo (CISSP, CIPP/C), CEO of Privacy Horizons, and will emphasize the importance of prioritizing privacy to enhance customer trust and ensure ethical data handling practices.
Learn about the value of:
Understanding privacy laws applicable to start-ups
Conducting comprehensive privacy impact assessments
Integrating privacy and security features into products and services
Establishing robust privacy management programs
Health Science Technology Training for Software and Data Professionals (Cohort 3)
As Canada accelerates the commercialization and adoption of digital technologies into the fast-growing health science industry, there is a critical need to create high-value technology jobs and support the development of talent in the technology workforce.
OBIO® is proud to partner with Upskill Canada [powered by Palette Skills] and the Government of Canada to deliver the third cohort of its national Health Science Technology Training for Software and Data Professionals. The training program will provide focused, digital technology development upskilling to help fast-growing companies access the talent they need to thrive and prosper, while creating new career paths for workers to quickly transition into high-demand roles.
THE PROGRAM RUNS FROM
SEPTEMBER 16 to DECEMBER 20, 2024 (14 WEEKS):
Part I – Core Training Course (Weeks 1 & 2)
Dates: September 16 - 27, 2024
Time: 9 am – 1 pm daily
Format: Virtual
Part II – Job placement support (Weeks 3 to 14).
Format: Hybrid
During this time, program participants will have access to a range of benefits:
Workshops for job placement support, including resume & interview preparation (virtual) and networking events (in person)
Applications will be accepted until August 25, 2024.
OBIO® WiHI Breakfast Series: Branding for Success
Once a month, the OBIO® WiHI Professional Network (WiHI) hosts a breakfast with successful and inspiring women, inviting them to share their experiences, challenges and successes as they build and grow their companies in Canada.
Upcoming Breakfast session:
June 27 | 9 – 10:30 am | Toronto
Branding for Success
The OBIO® Women in Health Initiative (WiHI) is excited to announce its upcoming breakfast session on June 27, featuring two guest speakers:
Marwah Younis
Advisor, Strategic Relationships | Canada’s Drug Agency
Marwah will discuss the transformative power of personal branding and how to strategically position yourself and your company. By immersing yourself in your desired field and leveraging tools like LinkedIn, you can create a compelling personal and business brand that opens doors and drives professional success.
Joanne Fedeyko
Founder & CEO | Connection Silicon Valley
Founder | Canadian Women's Network
Joanne will be introducing the Canadian Entrepreneurs in Life Science (CELS) Valley Ready program. If you are interested in the CELS Valley Ready program or would like to learn more about it, Joanne will be available to provide insights and answer questions.
This is an invitation-only event. Are you (or any women in your network) interested in attending? Click here and we will connect with you (or them).
Women in MedTech Networking Event
Join us in Toronto on June 26, from 5:30 - 8 pm, for an insightful evening of networking with professionals in the medtech industry at our Women in MedTech Networking Event!
Join us before the summer break kicks off! On June 26, the OBIO® Women in Health Initiative (WiHI) is hosting a networking event in Toronto in partnership with Cortex Design. This event will showcase women-led, early-stage companies at the forefront of the medtech industry.
This is a valuable opportunity to:
Hear from inspiring women leaders as they share their entrepreneurial journey and dive into the reason behind their passion for innovation
Gain valuable insights into their innovative work and key healthcare challenges they are solving
Network with medtech companies, investors, ecosystem partners and service providers in the industry
This is an invitation-only event. Are you (or any women in your network) interested in attending? Connect with us and we will get back to you (or them).
Meet our guest speakers
Rachel Bartholomew | Founder & CEO | Hyivy Health
Lianna Genovese | CEO & Founder | ImaginAble Solutions
Zaya MacDonald | Co-Founder & CEO | Hada MedTech
Kate Riley | CEO | Eye3Concepts
Monika Yazdanian | CEO | ToeFX Inc